866587-97-5 Usage
Uses
Used in Pharmaceutical Industry:
[4-isobutoxy-3-[(2-phenyl-1H-indol-1-yl)methyl]phenyl]methanol is used as a chemical intermediate for the development of new pharmaceuticals due to its potential pharmacological activity. The indole group within its structure suggests that it may interact with various biological targets, making it a promising candidate for the creation of novel drugs.
Used in Chemical Research:
[4-isobutoxy-3-[(2-phenyl-1H-indol-1-yl)methyl]phenyl]methanol is also used as a research tool in the field of organic chemistry to study its reactivity, stability, and potential to form new derivatives. Understanding its properties can contribute to the advancement of chemical knowledge and the development of new synthetic methods.
Used in Material Science:
Given its complex structure, [4-isobutoxy-3-[(2-phenyl-1H-indol-1-yl)methyl]phenyl]methanol may have applications in material science, potentially serving as a component in the development of new materials with specific properties, such as improved conductivity or enhanced stability.
Check Digit Verification of cas no
The CAS Registry Mumber 866587-97-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,5,8 and 7 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 866587-97:
(8*8)+(7*6)+(6*6)+(5*5)+(4*8)+(3*7)+(2*9)+(1*7)=245
245 % 10 = 5
So 866587-97-5 is a valid CAS Registry Number.
866587-97-5Relevant academic research and scientific papers
ALKOXYPHENYLPROPANOIC ACID DERIVATIVES
-
Page/Page column 37-38, (2008/06/13)
The present invention aims at provision of a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. The compound represented by the formula: wherein each symbol is as defined in the description, a salt thereof, and a prodrug thereof of the present invention unexpectedly have a superior GPR40 receptor agonistic activity and superior properties as pharmaceutical products such as stability and the like, and can be safe and useful pharmaceutical agents as agents for the prophylaxis or treatment of GPR40 receptor-related pathology or diseases in mammals.
